DXR vs PEAK
Daxor Corporation (DXR) versus PEAK (PEAK) — a side-by-side from cached financials, not a winner call.
Daxor Corporation (DXR) is a medical instruments & supplies company listed on US.
PEAK (PEAK) common stock.
Latest reported DXR revenue for 2011-12-31 was $1.4M. Net income was -$7.2M. Revenue was down 8.4% from 2010-12-31 to 2011-12-31. DXR currently screens at market cap $61.9M and trailing P/E 6.5.
PEAK does not have a complete income-statement cache yet.
DXR currently screens at market cap $61.9M and trailing P/E 6.5.
Not investment advice. Open the DXR and PEAK stock pages for the full models.
Not investment advice.